DLA PIPER LLP (US)
Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION · Advocacy organization for the biotechnology industry.
Federal proposals and policies impacting the innovative biotechnology industry, including: health care policies; Medicare payment, coverage, and reimbursement; drug pricing and supply chain issues; and the reauthorization of the Pandemic and All Hazards Preparedness Act.
Federal proposals and policies impacting the innovative biotechnology industry, including: health care policies; Medicare payment, coverage, and reimbursement; drug pricing and supply chain issues; and the reauthorization of the Pandemic and All Hazards Preparedness Act.
Federal proposals and policies impacting the innovative biotechnology industry, including: health care policies; Medicare payment, coverage, and reimbursement; drug pricing and supply chain issues; and the reauthorization of the Pandemic and All Hazards Preparedness Act.
Federal proposals and policies impacting the innovative biotechnology industry, including: health care policies; Medicare payment, coverage, and reimbursement; drug pricing and supply chain issues; and the reauthorization of the Pandemic and All Hazards Preparedness Act.